OXFORD--Wyeth-Ayerst Research has signed a deal with Oxford Molecular Group to license and install Oxford's RS3 Discovery client/server information management system enterprise-wide. According to Oxford, the pharmaceutical company will use the system for chemical registration, structure and substructure searching, and integrating biological assay data through a common Oracle-RS3 Discovery server.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.